PATENT CLAIM ANALYSIS

Application Number: 15937496
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-04
Patent Classification: ["514", "002400"]

Abstract:
Sulfanyl-tetrahydropyran-based compounds, pharmaceutical compositions comprising them, and methods of their use for the treatment of diseases and disorders such as diabetes and obesity are disclosed.

Claim (Index 24):
A compound of the formula: or a pharmaceutically acceptable salt thereof, wherein:\n R 1A  is independently hydrogen or optionally substituted alkyl, aryl or heterocycle; \n each R 6  is independently hydrogen, hydroxyl, halogen, amino, cyano, nitro, C\u2261CR 6A , OR 6A , SR 6A , SOR 6A , SO 2 R 6A , C(O)R 6A , CO 2 R 6A , CO 2 H, CON(R 6A )(R 6A ), CONH(R 6A ), CONH 2 , NHC(O)R 6A , NHSO 2 R 6A , or optionally substituted alkyl, aryl or heterocycle; \n each R 6A  is independently optionally substituted alkyl, aryl or heterocycle; \n each R 7  is independently hydrogen, hydroxyl, halogen, amino, cyano, nitro, C\u2261CR 7A , OR 7A , SR 7A , SOR 7A , SO 2 R 7A , C(O)R 7A , CO 2 R 7A , CO 2 H, CON(R 7A )(R 7A ), CONH(R 7A ), CONH 2 , NHC(O)R 7A , NHSO 2 R 7A , or optionally substituted alkyl, aryl or heterocycle; \n each R 7A  is independently optionally substituted alkyl, aryl or heterocycle; \n m is 1-3; and \n n is 1-3.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.16667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12041860', '12858666', '11862690', '14082786', '13925981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8208623298181191
- 35 USC 102 Novelty (BERT): 0.6392223363629604
- Combined Prediction Score: 0.8026983304726032
- Mean Citation Score: 501.768728
- Max Citation Score: 581.3088
- Similarity Product: 571.1716285160064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test